Addressing the opening ceremony of the National Conference on the Role and Application of Nuclear Technology in Health Care, Mohammad Eslami highlighted the significant achievements and ongoing advancements in Iran’s nuclear technology.
Eslami said that currently, 60 types of radiopharmaceuticals are being produced and distributed inside the country, with an additional 20 radiopharmaceuticals undergoing clinical trials.
He emphasized that such accomplishments are no exaggeration as they have been acknowledged by reputable international journals and
publications.
The AEOI chief also said that Iran’s heavy water production is of the highest quality across the world and efforts are continuously being made to expand its production.
“The radiopharmaceuticals produced in Iran have the potential for export, and we are already exporting them to other countries,” Eslami stated.
In the area of radiation therapy, he said that significant steps have been taken and resulted in a 2.5-fold increase compared to last year, adding that with the inauguration and operation of new centers, some of which are set to launch this month, substantial contributions to the healthcare sector are expected.
The two-day conference on the role and applications of nuclear technology in the healthcare system was held at Shahid Beheshti University in Tehran.